Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene M Stratton

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Acta Ophthalmologica|April 5, 2013
The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010Peter H Scanlon, Irene M Stratton, Mark Histed, et al.
The British Journal of Ophthalmology|April 27, 2021
Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohortJohn J Smith, David M Wright, Irene M Stratton, et al.
Eye (London, England)|December 4, 2018
Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathyJose Leal, Ramon Luengo-Fernandez, Irene M Stratton, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 10, 2004
Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69David R Matthews, Irene M Stratton, Stephen J Aldington, et al.
Diabetes Care|November 15, 2012
A simple risk stratification for time to development of sight-threatening diabetic retinopathyIrene M Stratton, Stephen J Aldington, David J Taylor, et al.
Diabetes Care|June 7, 2008
Preanalytical, analytical, and computational factors affect homeostasis model assessment estimatesSusan E Manley, Stephen D Luzio, Irene M Stratton, et al.
Diabetes Care|December 25, 2003
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66Richard J Stevens, Ruth L Coleman, Amanda I Adler, et al.
Diabetes Care|April 30, 2002
UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetesAmanda I Adler, Richard J Stevens, Andrew Neil, et al.
European Journal of Ophthalmology|December 17, 2013
Agreement between photographic screening and hospital biomicroscopy grading of diabetic retinopathy and maculopathyRachel Healy, Ahmed Sallam, Vanessa Jones, et al.
Health Technology Assessment (Winchester, England)|September 19, 2015
Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screeningPeter H Scanlon, Stephen J Aldington, Jose Leal, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Acta Ophthalmologica|April 5, 2013
The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010Peter H Scanlon, Irene M Stratton, Mark Histed, et al.
The British Journal of Ophthalmology|April 27, 2021
Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohortJohn J Smith, David M Wright, Irene M Stratton, et al.
Eye (London, England)|December 4, 2018
Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathyJose Leal, Ramon Luengo-Fernandez, Irene M Stratton, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 10, 2004
Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69David R Matthews, Irene M Stratton, Stephen J Aldington, et al.
Diabetes Care|November 15, 2012
A simple risk stratification for time to development of sight-threatening diabetic retinopathyIrene M Stratton, Stephen J Aldington, David J Taylor, et al.
Diabetes Care|June 7, 2008
Preanalytical, analytical, and computational factors affect homeostasis model assessment estimatesSusan E Manley, Stephen D Luzio, Irene M Stratton, et al.
Diabetes Care|December 25, 2003
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66Richard J Stevens, Ruth L Coleman, Amanda I Adler, et al.
Diabetes Care|April 30, 2002
UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetesAmanda I Adler, Richard J Stevens, Andrew Neil, et al.
European Journal of Ophthalmology|December 17, 2013
Agreement between photographic screening and hospital biomicroscopy grading of diabetic retinopathy and maculopathyRachel Healy, Ahmed Sallam, Vanessa Jones, et al.
Health Technology Assessment (Winchester, England)|September 19, 2015
Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screeningPeter H Scanlon, Stephen J Aldington, Jose Leal, et al.
Pageof 4